Prediction of Muscle Responsiveness to FES Therapy
Point-of-care Prediction of Muscle Responsiveness to Functional Electrical Stimulation Therapy During Neurorehabilitation (sub-study)
1 other identifier
interventional
10
1 country
1
Brief Summary
Reduced arm and hand function has a significant impact on independence and quality of life after spinal cord injury. Functional electrical stimulation therapy (FES-T) is a treatment that can produce improvements in reaching and grasping function after neurological injuries. However, not all paralyzed muscles respond equally well to the therapy. Currently, therapists cannot predict which muscles will respond, limiting their ability to create a personalized therapy plan that can maximize outcomes while making the best use of the limited treatment time available. The objective of this study is to develop a diagnostic method that will allow therapists to quickly and easily screen muscles in the clinic, in order to predict how they will respond to FES-T. Participants with cervical spinal cord injury will receive FES-T through the Rocket Family Upper Extremity Clinic at the Toronto Rehabilitation Institute - University Health Network. Muscles receiving training will undergo a electrophysiological examination before the start of therapy, and will then be tracked for strength recovery over the course of 30 sessions. Lastly, signal processing and machine learning techniques will be applied to the electrophysiological data to predict the recovery profile of each muscle. The significance of this work will be to provide personalized therapy planning in FES-T, leading to more effective use of healthcare resource as well as improved outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 4, 2022
CompletedFirst Posted
Study publicly available on registry
July 18, 2022
CompletedStudy Start
First participant enrolled
July 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJanuary 15, 2025
January 1, 2025
2.5 years
July 4, 2022
January 13, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Muscle strength recovery profile
Change over time in manual muscle testing conducted on each treated muscle.
Muscle strength assessed at each of 30 therapy sessions (3-5 sessions per week).
Secondary Outcomes (1)
Surface electromyography signal features
Baseline (required). End of therapy (6-10 weeks; optional).
Study Arms (1)
Functional electrical stimulation therapy
EXPERIMENTALParticipants will receive 30 sessions of upper limb functional electrical stimulation therapy. Sessions will be 1 hour in length and take place 3-5 times per week.
Interventions
Functional electrical stimulation therapy will be delivered using the MyndMove system (MyndTec, Inc., Mississauga, Canada).
Eligibility Criteria
You may qualify if:
- Cervical spinal cord injury
- Paralysis or paresis in at least one upper extremity
- At least 6 months post SCI
- Able to understand and follow instructions
- Able to tolerate being in a seated position for a least one hour required to deliver upper limb therapy
- Willing to attend treatment sessions and all assessment sessions
- Able to understand and provide informed consent
- Male and female participants ≥ 18 years of age at the time of enrollment
You may not qualify if:
- Previous history of any other neuromuscular disorder or conditions that may affect motor response
- Upper extremity injury or condition prior to SCI that limits the function of the hand or arm
- In the judgment of the medical provider, the participant has medical complications that may interfere with the execution of the study
- Currently enrolled in another upper limb study and/ or has received MyndMove Therapy within the past 3 months
- Botulinum toxin injection into affected upper extremity and the muscle targeted by MyndMove® therapy within 3 months prior to the study start. No botulinum toxin injections in the upper extremity during the study treatment.
- Females who are pregnant or planning to become pregnant in the duration of the trial
- Regional disorder of the upper extremities such as fracture, dislocation, or joint contractures to less than 50% of the expected range of motion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Health Network, Torontolead
- Wings for Lifecollaborator
Study Sites (1)
Toronto Rehabilitation Institute - University Health Network
Toronto, Ontario, M4G 3V9, Canada
Related Publications (1)
Balbinot G, Li G, Chen A, Eftekhar P, Ma W, Kalsi-Ryan S, Zariffa J. Upper Extremity Muscle Recovery Profiles With Functional Electrical Stimulation Therapy in Chronic Spinal Cord Injury. Neuromodulation. 2025 Oct 16:S1094-7159(25)01026-8. doi: 10.1016/j.neurom.2025.08.416. Online ahead of print.
PMID: 41099684DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
José Zariffa, PhD
University Health Network, Toronto
- PRINCIPAL INVESTIGATOR
Sukhvinder Kalsi-Ryan, PhD
University Health Network, Toronto
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 4, 2022
First Posted
July 18, 2022
Study Start
July 20, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
January 15, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Once study has been published, the datasets corresponding to the analyses described will be shared upon request.
- Access Criteria
- Data sharing will require completion of a data sharing agreement. Interested parties should contact the principal investigator.
De-identified data may be shared following study completion upon reasonable request to the investigators and completion of a data sharing agreement.